Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver FitzGerald

Showing results (141-150 of 288) with videos related to

Pageof 29
Sort By:
FEBS Letters|September 11, 2003
Identification of Naf1/ABIN-1 among TNF-alpha-induced expressed genes in human synoviocytes using oligonucleotide microarraysJoanne Gallagher, Jillian Howlin, Conor McCarthy, et al.
Arthritis Research & Therapy|July 25, 2009
Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapiesEllen M Moran, Ronan Mullan, Jennifer McCormick, et al.
Arthritis Research & Therapy|August 23, 2023
Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studiesPhilip J Mease, Ana-Maria Orbai, Oliver FitzGerald, et al.
Annals of the Rheumatic Diseases|May 6, 2017
Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritisPhilip J Mease, Alice B Gottlieb, Désirée van der Heijde, et al.
Autoimmunity Reviews|February 5, 2017
Effects of targeted therapies on the bone in arthritidesÁgnes Szentpétery, Ágnes Horváth, Katalin Gulyás, et al.
Arthritis Research & Therapy|March 26, 2021
Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinibLaura C Coates, Andrew G Bushmakin, Oliver FitzGerald, et al.
BMC Musculoskeletal Disorders|January 21, 2009
Exercise and manual physiotherapy arthritis research trial (EMPART): a multicentre randomised controlled trialHelen P French, Tara Cusack, Aisling Brennan, et al.
Clinical and Experimental Rheumatology|August 2, 2022
Differentiating patients with psoriasis from psoriatic arthritis using collagen biomarkersSigne Holm Nielsen, Conor Magee, Solveig S Groen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 11, 2021
Identification and Evaluation of Serum Protein Biomarkers That Differentiate Psoriatic Arthritis From Rheumatoid ArthritisAngela Mc Ardle, Anna Kwasnik, Agnes Szentpetery, et al.
Current Rheumatology Reports|September 22, 2020
Aiming for Cure and Preventive Initiatives in Psoriatic Disease: Building Synergy at NPF, GRAPPA, and PPACMANStacie Bell, Joseph F Merola, Dan E Webster, et al.
Pageof 29

Showing results (141-150 of 288) with videos related to

Sort By:
Pageof 29
FEBS Letters|September 11, 2003
Identification of Naf1/ABIN-1 among TNF-alpha-induced expressed genes in human synoviocytes using oligonucleotide microarraysJoanne Gallagher, Jillian Howlin, Conor McCarthy, et al.
Arthritis Research & Therapy|July 25, 2009
Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapiesEllen M Moran, Ronan Mullan, Jennifer McCormick, et al.
Arthritis Research & Therapy|August 23, 2023
Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studiesPhilip J Mease, Ana-Maria Orbai, Oliver FitzGerald, et al.
Annals of the Rheumatic Diseases|May 6, 2017
Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritisPhilip J Mease, Alice B Gottlieb, Désirée van der Heijde, et al.
Autoimmunity Reviews|February 5, 2017
Effects of targeted therapies on the bone in arthritidesÁgnes Szentpétery, Ágnes Horváth, Katalin Gulyás, et al.
Arthritis Research & Therapy|March 26, 2021
Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinibLaura C Coates, Andrew G Bushmakin, Oliver FitzGerald, et al.
BMC Musculoskeletal Disorders|January 21, 2009
Exercise and manual physiotherapy arthritis research trial (EMPART): a multicentre randomised controlled trialHelen P French, Tara Cusack, Aisling Brennan, et al.
Clinical and Experimental Rheumatology|August 2, 2022
Differentiating patients with psoriasis from psoriatic arthritis using collagen biomarkersSigne Holm Nielsen, Conor Magee, Solveig S Groen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 11, 2021
Identification and Evaluation of Serum Protein Biomarkers That Differentiate Psoriatic Arthritis From Rheumatoid ArthritisAngela Mc Ardle, Anna Kwasnik, Agnes Szentpetery, et al.
Current Rheumatology Reports|September 22, 2020
Aiming for Cure and Preventive Initiatives in Psoriatic Disease: Building Synergy at NPF, GRAPPA, and PPACMANStacie Bell, Joseph F Merola, Dan E Webster, et al.
Pageof 29